Completed
BL22 Immunotoxin in Treating Patients Previously Treated With Cladribine for Hairy Cell Leukemia
NCT00074048
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States